Ranch Capital Advisors Inc. Crispr Therapeutics Ag Transaction History

Ranch Capital Advisors Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$70.09 - $111.29 $124,900 - $198,318	-1,782 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $20,938 - $29,761	190 Added 11.93%	1,782 $199,000
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $19,159 - $30,759	190 Added 13.55%	1,592 $257,000
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $75,843 - $143,877	685 Added 95.54%	1,402 $170,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $5,975 - $12,992	75 Added 11.68%	717 $109,000
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $22,137 - $28,380	282 Added 78.33%	642 $53,000
Q2 2020 Aug 12, 2020	BUY	$38.5 - $76.05 $13,860 - $27,378	360 New	360 $32,000

490

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.02B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Ranch Capital Advisors Inc. with notifications on news.